An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

A Harari, PA Bart, W Stöhr, G Tapia… - The Journal of …, 2008 - rupress.org
The EuroVacc 02 phase I trial has evaluated the safety and immunogenicity of a prime-boost
regimen comprising recombinant DNA and the poxvirus vector NYVAC, both expressing a …

HIV-1 DNA predicts disease progression and post-treatment virological control

JP Williams, J Hurst, W Stöhr, N Robinson, H Brown… - elife, 2014 - elifesciences.org
10.7554/eLife.03821.001 In HIV-1 infection, a population of latently infected cells facilitates
viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in …

Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized …

JA Bielicki, W Stöhr, S Barratt, D Dunn, N Naufal… - Jama, 2021 - jamanetwork.com
Importance The optimal dose and duration of oral amoxicillin for children with community-acquired
pneumonia (CAP) are unclear. Objective To determine whether lower-dose …

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy

A Reid, W Stöhr, AS Walker, IG Williams… - Clinical infectious …, 2008 - academic.oup.com
Background . We sought to investigate renal function in previously untreated symptomatic
human immunodeficiency virus (HIV)–infected adults with CD4 + cell counts of <200 cells/mm …

[HTML][HTML] Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis …

NJ Russell, W Stöhr, N Plakkal, A Cook… - PLoS …, 2023 - journals.plos.org
Background There is limited data on antibiotic treatment in hospitalized neonates in low-
and middle-income countries (LMICs). We aimed to describe patterns of antibiotic use, …

Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication

W Stöhr, D Back, D Dunn, C Sabin… - Antiviral …, 2008 - journals.sagepub.com
Background The aim of this study was to examine factors influencing plasma concentration
of efavirenz and nevirapine. Methods Data from the Liverpool Therapeutic Drug Monitoring (…

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the …

S Fidler, W Stöhr, M Pace, L Dorrell, A Lever, S Pett… - The Lancet, 2020 - thelancet.com
Background Antiretroviral therapy (ART) cannot cure HIV infection because of a persistent
reservoir of latently infected cells. Approaches that force HIV transcription from these cells, …

[HTML][HTML] Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial

NI Paton, W Stöhr, A Arenas-Pinto, M Fisher… - The lancet HIV, 2015 - thelancet.com
Background Standard-of-care antiretroviral therapy (ART) uses a combination of drugs deemed
essential to minimise treatment failure and drug resistance. Protease inhibitors are potent…

[HTML][HTML] Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy

W Stöhr, S Fidler, M McClure, J Weber, D Cooper… - PloS one, 2013 - journals.plos.org
Objective A minority of HIV-1 positive individuals treated with antiretroviral therapy (ART) in
primary HIV-1 infection (PHI) maintain viral suppression on stopping. Whether this is related …

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial

F Ssali, W Stöhr, P Munderi, A Reid… - Antiviral …, 2006 - journals.sagepub.com
Objective To describe the prevalence, incidence and predictors of severe anaemia in previously
untreated symptomatic HIV-infected adults with CD4 + T-cells <200 cells/mm 3 initiating …